Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma
This study has been completed.
Sponsor:
University of Wisconsin, Madison
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00581854
First received: December 19, 2007
Last updated: December 9, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2010 |
| Primary Completion Date: | June 2006 (Final data collection date for primary outcome measure) |